SVB Leerink: This “holy grail” of the vaccine industry could be worth $10 billion

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

  • We don’t have a fire season, we have a fire year, says Cal Fire director
  • Shorter work week makes a happier workforce and that’s a win-win, says journalist
  • MLB’s Cleveland Indians to become the Guardians, starting in 2022
  • CNBC Television published this video item, entitled “SVB Leerink: This “holy grail” of the vaccine industry could be worth $10 billion” – below is their description.

    Geoffrey Porges, SVB Leerink Director of Therapeutics Research and Senior Biotechnology Analyst, joins Worldwide Exchange to discuss his latest note on the RSV vaccine development industry.

    CNBC Television YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    Leave a Comment